ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669739 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669739; 2) Community: the network communities that were significantly associated with the response to NSC 669739; 3) Molecule: the relationships between components within communities and NSC 669739; 4) MDR: the compounds that were significantly associated with the NSC 669739.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.00701295499506023 0.065568678
NSC 113951 6-Bromotoyocamycin 0.00714731931708452 0.034663585
NSC 328130 Null 0.00714731931708452 -0.067129774
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.00714731931708452 -0.30602991
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.00714731931708452 0.070871694
NSC 652151 Null 0.00714731931708452 -0.082829066
NSC 670788 Null 0.00714731931708452 -0.094300772
NSC 689727 Null 0.00714731931708452 -0.067944332
NSC 83223 Silver methanesulfonate (Ag(CH2SO3)) 0.00714731931708452 -0.12074869
NSC 658455 (S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine 0.00770426557728501 -0.27196503
Total:50  Current:7    [First] [Prev] [Next] [Last]